SEC Form 4 · accession 0001127602-18-025253
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Aug 13, 2018
Accepted (ET)
Aug 14, 2018 · 1:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2018 | M | 1,249 | $76.12 | A | 13,690 | D | |
| Common Stock | Aug 13, 2018 | S | 200 | $119.20 | D | 13,490 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $119.59 | D | 13,390 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $119.65 | D | 13,290 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $119.82 | D | 13,190 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $119.91 | D | 13,090 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $120.04 | D | 12,990 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $120.27 | D | 12,890 | D | |
| Common Stock | Aug 13, 2018 | S | 149 | $120.35 | D | 12,741 | D | |
| Common Stock | Aug 13, 2018 | S | 64 | $120.58 | D | 12,677 | D | |
| Common Stock | Aug 13, 2018 | S | 36 | $120.805 | D | 12,641 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $120.81 | D | 12,541 | D | |
| Common Stock | Aug 13, 2018 | S | 100 | $121.01 | D | 12,441 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.12 | Aug 13, 2018 | M | 1,249 | D | Aug 12, 2016 | Aug 12, 2020 | Common Stock | 1,249 | 1,249 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.